An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Researchers at Barts Cancer Institute reveal promising acute myeloid leukaemia treatment targeting fat metabolism, addressing the urgent need for better therapies.